List of works - Yen Y Tan

Alcohol Consumption, Cigarette Smoking, and Risk of Breast Cancer for BRCA1 and BRCA2 Mutation Carriers: Results from The BRCA1 and BRCA2 Cohort Consortium

scientific article published on 02 December 2019

Association between family history, mutation locations, and prevalence of BRCA1 or 2 mutations in ovarian cancer patients

scientific article published on 01 March 2019

Association of Genomic Domains in BRCA1 and BRCA2 with Prostate Cancer Risk and Aggressiveness

scientific article published on 13 November 2019

Association of breast cancer risk in BRCA1 and BRCA2 mutation carriers with genetic variants showing differential allelic expression: identification of a modifier of breast cancer risk at locus 11q22.3.

scientific article

Barriers and motivators for referral of patients with suspected lynch syndrome to cancer genetic services: a qualitative study

scientific article

Cadherin-11 expression is upregulated in invasive human breast cancer

scientific article published on 10 October 2016

Diagnostic markers for the detection of ovarian cancer in BRCA1 mutation carriers.

scientific article published on 15 December 2017

Differential Claudin 3 and EGFR Expression Predicts BRCA1 Mutation in Triple-Negative Breast Cancer

scientific article published on 24 August 2018

Endometrial cancer risk and survival by tumor MMR status.

scientific article

Estradiol impairs the antiproliferative and proapoptotic effect of Zoledronic acid in hormone sensitive breast cancer cells in vitro.

scientific article published on 25 September 2017

Expression of ezrin and moesin in primary breast carcinoma and matched lymph node metastases.

scientific article published on 17 June 2017

Family history of cancer predicts endometrial cancer risk independently of Lynch Syndrome: Implications for genetic counselling.

scientific article

Fine-mapping of 150 breast cancer risk regions identifies 191 likely target genes

scientific article published on 07 January 2020

Gender differences in risk factors for coronary heart disease

scientific article

Identification and management of familial breast cancer in Austria.

scientific article published on 30 November 2017

Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer

scientific article

Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer

scientific article published on 23 October 2017

Improving comprehension of genetic counseling for hereditary breast and ovarian cancer clients with a visual tool

scientific article published in PLoS ONE

Improving identification of lynch syndrome patients: a comparison of research data with clinical records

scientific article

Knowledge, attitudes and referral patterns of lynch syndrome: a survey of clinicians in australia

scientific article

Mutational Spectrum in a Worldwide Study of 29,700 Families with BRCA1 or BRCA2 Mutations

scientific article published on 15 February 2018

PTEN expression as a predictor for the response to trastuzumab-based therapy in Her-2 overexpressing metastatic breast cancer.

scientific article

Pathological Complete Response to Neoadjuvant Trastuzumab Is Dependent on HER2/CEP17 Ratio in HER2-Amplified Early Breast Cancer.

scientific article published on 31 January 2017

Prediction of Breast and Prostate Cancer Risks in Male BRCA1 and BRCA2 Mutation Carriers Using Polygenic Risk Scores

scientific article

RANKL/RANK control Brca1 mutation-driven mammary tumors

scientific article published on 31 May 2016

Reply to J. Moline et al

scientific article published on 09 June 2014

Risks of Breast, Ovarian, and Contralateral Breast Cancer for BRCA1 and BRCA2 Mutation Carriers

scientific article published on June 2017

Tumor mismatch repair immunohistochemistry and DNA MLH1 methylation testing of patients with endometrial cancer diagnosed at age younger than 60 years optimizes triage for population-level germline mismatch repair gene mutation testing.

scientific article

List of works by Yen Y Tan

Alcohol Consumption, Cigarette Smoking, and Risk of Breast Cancer for BRCA1 and BRCA2 Mutation Carriers: Results from The BRCA1 and BRCA2 Cohort Consortium

Association between family history, mutation locations, and prevalence of BRCA1 or 2 mutations in ovarian cancer patients

Association of Genomic Domains in BRCA1 and BRCA2 with Prostate Cancer Risk and Aggressiveness

Association of breast cancer risk in BRCA1 and BRCA2 mutation carriers with genetic variants showing differential allelic expression: identification of a modifier of breast cancer risk at locus 11q22.3.

Barriers and motivators for referral of patients with suspected lynch syndrome to cancer genetic services: a qualitative study

Cadherin-11 expression is upregulated in invasive human breast cancer

Diagnostic markers for the detection of ovarian cancer in BRCA1 mutation carriers.

Differential Claudin 3 and EGFR Expression Predicts BRCA1 Mutation in Triple-Negative Breast Cancer

Endometrial cancer risk and survival by tumor MMR status.

Estradiol impairs the antiproliferative and proapoptotic effect of Zoledronic acid in hormone sensitive breast cancer cells in vitro.

Expression of ezrin and moesin in primary breast carcinoma and matched lymph node metastases.

Family history of cancer predicts endometrial cancer risk independently of Lynch Syndrome: Implications for genetic counselling.

Fine-mapping of 150 breast cancer risk regions identifies 191 likely target genes

Gender differences in risk factors for coronary heart disease

Identification and management of familial breast cancer in Austria.

Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer

Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer

Improving comprehension of genetic counseling for hereditary breast and ovarian cancer clients with a visual tool

Improving identification of lynch syndrome patients: a comparison of research data with clinical records

Knowledge, attitudes and referral patterns of lynch syndrome: a survey of clinicians in australia

Mutational Spectrum in a Worldwide Study of 29,700 Families with BRCA1 or BRCA2 Mutations

PTEN expression as a predictor for the response to trastuzumab-based therapy in Her-2 overexpressing metastatic breast cancer.

Pathological Complete Response to Neoadjuvant Trastuzumab Is Dependent on HER2/CEP17 Ratio in HER2-Amplified Early Breast Cancer.

Prediction of Breast and Prostate Cancer Risks in Male BRCA1 and BRCA2 Mutation Carriers Using Polygenic Risk Scores

RANKL/RANK control Brca1 mutation-driven mammary tumors

Reply to J. Moline et al

Risks of Breast, Ovarian, and Contralateral Breast Cancer for BRCA1 and BRCA2 Mutation Carriers

Tumor mismatch repair immunohistochemistry and DNA MLH1 methylation testing of patients with endometrial cancer diagnosed at age younger than 60 years optimizes triage for population-level germline mismatch repair gene mutation testing.